NATCO Pharma Limited Stock Forecast
NATCO Pharma Limited stock upgraded from Hold/Accumulate to Buy Candidate after Thursday trading session.
(Updated on May 23, 2024)
The NATCO Pharma Limited stock price gained 2.20% on the last trading day (Thursday, 23rd May 2024), rising from ₹1,003.05 to ₹1,025.10. It has now gained 3 days in a row. It will be exciting to see whether it manages to continue gaining or take a minor break for the next few days. During the last trading day the stock fluctuated 3.30% from a day low at ₹998.05 to a day high of ₹1,031.00. The price has risen in 7 of the last 10 days and is up by 5.72% over the past 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 341 thousand more shares were traded than the day before. In total, 565 thousand shares were bought and sold for approximately ₹579.27 million.
The stock lies in the upper part of a weak rising trend in the short term, and this may normally pose a very good selling opportunity for the short-term trader as reaction back towards the lower part of the trend can be expected. A break-up at the top trend line at ₹1,039.67 will firstly indicate a stronger rate of rising. Given the current short-term trend, the stock is expected to rise 2.31% during the next 3 months and, with a 90% probability hold a price between ₹974.54 and ₹1,063.68 at the end of this 3-month period.
Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.
NATCOPHARM.NS Signals & Forecast
The NATCO Pharma Limited stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at ₹999.90 and ₹998.01. A breakdown below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Thursday, May 09, 2024, and so far it has risen 5.72%. Further rise is indicated until a new top pivot has been found. Volume is rising along with the price. This is considered to be a good technical signal. Some negative signals were issued as well, and these may have some influence on the near short-term development. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD).
Support, Risk & Stop-loss for NATCO Pharma Limited stock
NATCO Pharma Limited finds support from accumulated volume at ₹1,021.15 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.
In general the stock tends to have very controlled movements and with good liquidity the risk is considered very low in this stock. During the last day, the stock moved ₹32.95 between high and low, or 3.30%. For the last week the stock has had daily average volatility of 1.44%.
Our recommended stop-loss: ₹983.48 (-4.06%) (This stock has low daily movements and this gives low risk. There is a buy signal from a pivot bottom found 64 days ago.)
Trading Expectations (NATCOPHARM.NS) For The Upcoming Trading Day Of Friday 24th
For the upcoming trading day on Friday, 24th we expect NATCO Pharma Limited to open at ₹1,018.05, and during the day (based on 14 day Average True Range), to move between ₹1,000.35 and ₹1,049.85, which gives a possible trading interval of +/-₹24.75 (+/-2.41%) up or down from last closing price. If NATCO Pharma Limited takes out the full calculated possible swing range there will be an estimated 4.83% move between the lowest and the highest trading price during the day.
Since the stock is closer to the resistance from accumulated volume at ₹1,026.05 (0.09%) than the support at ₹1,021.15 (0.39%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.
Earnings coming up
NATCO Pharma Limited will release earnings BMO on Monday, May 27, 2024. We will update the financials statements for NATCO Pharma Limited, that can be found here as soon as the records are public. Our systems has calculated a possible swing of +/- 3.36% in the first trading day after earnings release.
Is NATCO Pharma Limited stock A Buy?
Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for NATCO Pharma Limited stock to perform well in the short-term. We have upgraded our analysis conclusion for this stock since the last evaluation from a Hold/Accumulate to a Buy candidate.
Current score: 4.453 Buy Candidate Upgraded
Predicted Opening Price for NATCO Pharma Limited of Friday, May 24, 2024
| Fair opening price May 24, 2024 | Current price |
|---|---|
| ₹1,018.05 ( 0.688%) | ₹1,025.10 |
The predicted opening price is based on yesterday's movements between high, low, and closing price.
Trading levels for NATCOPHARM.NS
Fibonacci Support & Resistance Levels
| Level | Price | |||
|---|---|---|---|---|
| Resistance | R3 | 1,051.00 | 2.53 % | |
| R2 | 1,038.41 | 1.30 % | ||
| R1 | 1,030.64 | 0.540 % | ||
| Current price: | 1,025.10 | |||
| Support | S1 | 1,005.46 | -1.92 % | |
| S2 | 997.69 | -2.67 % | ||
| S3 | 985.10 | -3.90 % |
Accumulated Volume Support & Resistance Levels
| Level | Price | |||
|---|---|---|---|---|
| Resistance | R3 | 1,034.10 | 0.88 % | |
| R2 | 1,027.90 | 0.273 % | ||
| R1 | 1,026.05 | 0.0927 % | ||
| Current price | 1,025.10 | |||
| Support | S1 | 1,021.15 | -0.385% | |
| S2 | 1,020.20 | -0.478% | ||
| S3 | 988.55 | -3.57% |
NATCOPHARM Dividend Payout History
| # | Ex-Date | Pay Date | Amount | Yield | |
|---|---|---|---|---|---|
| 1 | Feb 26, 2024 | Feb 26, 2024 | Mar 04, 2024 | ₹1.25 | 0.126% |
| 2 | Nov 24, 2023 | Nov 24, 2023 | Nov 24, 2023 | ₹0 | 0% |
| 3 | Feb 21, 2023 | Feb 21, 2023 | Feb 21, 2023 | ₹1.25 | 0.228% |
| 4 | Nov 21, 2022 | Nov 21, 2022 | Nov 21, 2022 | ₹0.750 | 0.132% |
| 5 | Aug 19, 2022 | Aug 19, 2022 | Aug 19, 2022 | ₹3.50 | 0.541% |
FAQ
Click here for our free guide on how to buy NATCO Pharma Limited Stock.
